Skip to content
Buy This GLP
← Research
Evidence

Do GLP-1 Drugs Help Lipedema? What the Studies Found

A large survey and small case series reported changes in health, symptoms, or limb measurements. The effect of the drugs on lipedema remains uncertain.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
PROMIS-10 medians — 50 is the population mean50physical, current42.3physical, never39.1mental, current44.9mental, never40.82,719 survey respondentsHealth scores were collected at one time.

GLP-1 drugs are being studied in people with lipedema, a condition involving disproportionate fat accumulation, most often in the legs. Studies of fat and lean mass during GLP-1 weight loss measure overall body composition. Lipedema research needs to measure effects in affected tissue and on symptoms such as pain and swelling.[1][3]

What the survey found

In the 2026 online survey (n = 2,719), about 55% of respondents were current users of a GLP-1 or dual GIP/GLP-1 drug, most often tirzepatide. Among respondents who reported why they used these medicines, 67.2% cited weight management and 19.3% cited lipedema symptoms as the main reason. Current users reported median physical health scores of 42.3 versus 39.1 among never-users, and mental health scores of 44.9 versus 40.8.[1]

Participants answered the questionnaire once and recalled changes since starting medication. The groups may have differed before treatment, and the survey could not determine how much of the difference, if any, the medication caused.[1]

What the small clinical reports measured

A 2025 case series described five women with lipedema and insulin resistance who received exenatide, some alongside lifestyle changes. A November 2026 report followed five women with lipedema and excess body weight through diet and exercise changes. Four later added tirzepatide. In the latter series, lower-limb measurements and subcutaneous fat thickness generally decreased, with variation between participants.[2][3]

Frequently asked

Do GLP-1 drugs help lipedema?
A survey and small case series reported some favorable findings. The evidence does not establish how well GLP-1 drugs treat lipedema itself.
Have researchers measured fat in areas affected by lipedema?
The 2026 case series measured subcutaneous fat thickness and limb size. Participants also changed diet and exercise, so the report cannot isolate the effect of tirzepatide or show a lipedema-specific effect.

Sources

  1. [1] Srinivasan A, Kartt J, Daftuar F, et al. (2026). GLP-1 and GLP-1/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey Obesity Pillars. PMID 42656629
  2. [2] Patton L, Reverdito V, Bellucci A, et al. (2025). A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide Clinics and Practice. PMID 40710038
  3. [3] Kędzierska-Kapuza K, Samul-Jastrzębska J, Cygler M, Jerzak M, Franek E (2026). A Multimodal Intervention Including Tirzepatide in Women with Lipedema and Excess Body Weight: A Pilot Case Series Journal of Clinical Medicine. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence